来源 :格隆汇2023-02-22
根据联交所最新权益披露资料显示,2023年2月17日,昭衍新药(06127.HK)获Aggregate of abrdn plc affiliated investment management entities在场内以每股均价35.4186港元增持10.5万股,涉资约271.9万港元。
增持后,Aggregate of abrdn plc affiliated investment management entities最新持股数目为769.18万股,持股比例由8.93%上升至9.05%。